The acetylcholine receptor from vertebrate skeletal muscle is a transmembrane channel that binds nervereleased acetylcholine to elicit rapid transport of small cations. Composed of two a subunits and one (3, one y, and one 8 subunit, the receptor is a cooperative protein containing two sites that bind agonists, curariform antagonists, and snake a-toxins. Until recently the two binding sites were thought to reside entirely within each of the two a subunits, but affinity labeling and expression studies have demonstrated contributions by the yand 8 subunits. Affinity labeling and mutagenesis studies have identified residues of the a subunit that contribute to the binding site, but the corresponding y-and 8-subunit residues remain unknown. By making y-8 chimeras and following the nearly 100-fold difference in curare affinity for the two binding sites, the present work identified residues ofthe y and 8 subunits likely to be near the binding site. Two sets of binding determinants were identified in homologous positions of the y and 8 subunits. The determinants lie on either side of a disulfide loop found within the major extracellular domain of the subunits. This loop is common to all acetylcholine, -aminobutyrate, and glycine receptor subunits.
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In the native acetylcholine receptor (AChR), the two ligand binding sites show very different affinities for both acetylcholine (1) and curariform antagonists (2, 3) . Because acetylcholine must occupy both sites to open the channel, the high-affinity site allows priming of the AChR for rapid activation, whereas the low-affinity site causes the AChR to shut off abruptly following a stimulus (4) . For curare, the affinity difference means that it blocks activation by binding to only the high-affinity site (3) . The molecular basis for the different affinities is thought to reside within the portions of the y and 8 subunits that contact the two a subunits to form the binding sites.
Recent work showed that AChRs lacking either a 'y or a 6 subunit assemble into pentamers with subunit compositions, a2,83yt and a2/362 (5) . More symmetrical than native a2,3yS
AChRs, these triplet AChRs bind curare with a single affinity-high affinity for a2Ay2 and low affinity for a2136-to quantitatively account for the two affinities seen in the native AChR. Thus, studies of triplet AChRs, as well as studies of ary and a6 subunit pairs (6) , demonstrate that the y subunit confers high affinity for curare, whereas the 8 subunit confers low affinity. In the work described here, determinants responsible for the different curare affinities were identified by constructing &-y subunit chimeras, coexpressing them with a and P subunits, and measuring binding of the curariform antagonist (+)-dimethyltubocurarine (DMT). METHODS
Construction of Chimeras and Point Mutations. Mouse
AChR cDNAs (7, 8) were subcloned into a cytomegalovirus-
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based expression vector (9) . Mutations were introduced either by ligating DNA fragments at common restriction sites, or by identifying restriction sites on either side of the desired mutation, and bridging the two sites with synthetic doublestranded oligonucleotides. Chimeras are designated as follows: the first letter gives the subunit from which N-terminal sequence is taken, G for y and D for 8; the following number gives the position ofthe chimericjunction, using the 8 subunit as reference, and the final letter gives the subunit for C-terminal sequences. All constructs were confirmed by restriction mapping and dideoxy sequencing. Chimeras and mutant subunits were constructed as follows. D225G. Delta-pRBG4 was digested with Ear I to yield an 1800-bp fragment, which was treated with mung bean nuclease followed by Xba I to yield a 760-bp 8 fragment. GammapRBG4 was digested with Ava I to yield an 1193-bp fragment, which was digested with Ear I to yield a 407-bp y fragment. After treatment with the Klenow fragment of DNA polymerase I in the presence ofthe four dNTPs, the 407-bp yfragment was digested with AlwNI to yield the 362-bp y fragment. Gamma-pRBG4 was digested with Xba I and AlwNI, and the resulting 2820-and 1580-bp fragments were religated and digested with Xba I to yield the 4400-bp AlwNI-Xba I y fragment. The 760-bp 6, 407-bp y, and 4400-bp y fragments were ligated to yield D225G.
GIOOD225G. Gamma-pRBG4 was digested with Spe I and then BstEII to yield a 3900-bp y fragment. Gamma-pRBG4 was digested with TthlllI and Spe I to yield a 1050-bp y fragment. D225G was digested with Spe I and BstEII to yield a 1700-bp fragment, which was digested with Bpm I to yield the 590-bp 6-y Bpm I-BstEII fragment. The 3900-bp BstEIISpe I 'y, 1050-bp Spe I-TthlllI 'y, and 590-bp Bpm I-BstEII 6-y fragments were ligated in the presence of the trinucleotide GCT to yield G1OOD225G.
G175D225G Postdisulftde chimeras (Fig. 3B ). These were constructed as described for G131D156G in Fig. 2 , by changing the oligonucleotide cassette (I) as needed.
Postdisulfide chimeras (Fig. 3C ). G175D225G was digested with PflMI and BstXI to yield a 5503-bp PflMI-BstXI fragment, which was ligated to oligonucleotide V, ATGGGAACAACAGATCTTACCCCATTGA CTCCTACCCTTGTTGTCTAGAATGGGGTA, to yield postdisulfide chimera 1 (see Fig. 3C , second row). Additional postdisulfide chimeras was prepared by changing the oligonucleotide cassette (V) as needed.
y predisulfide point mutants. These were constructed as described for predisulfide chimera 2, by changing the oligonucleotide cassette (II) as needed. chimera G131D225G, produced a surprising but interesting binding profile. Affinity was intermediate between that of y and 8, showing that the binding determinants cannot reside in a single residue but must involve two or more residues. These results place binding determinants in the vicinity of a disulfide loop, a motif found throughout the ligand-gated channel superfamily (10) . Neglecting the serine/proline mismatch within the loop, two sets of binding determinants can be defined: predisulfide and postdisulfide (Fig. 2) . A final chimera, G131D156G, contained 'y sequences everywhere except for 25 8 residues in the center of this 75-residue region. The resulting construct produced pure rlike binding, excluding this 25-residue portion from either set of binding determinants.
G(S161K
To identify binding determinants within the predisulfide domain, the y-6 junction in G131D156G was expanded 17 residues from the beginning of the disulfide loop toward the N terminus (Fig. 3A, second row) . The resulting construct produced intermediate affinity, as was seen in the original chimera bisecting this region (G131D225G). Intermediate affinity was observed, rather than pure 8 affinity, because the D225G GlOOD225G G175D225G G131D225G G131D156G postdisulfide residues were still y. The predisulfide binding determinants are therefore likely to be within this 17-residue segment. Two more chimeras narrowed the predisulfide determinants to two residues, a valine-threonine pair in 8 and an isoleucine-tyrosine pair in y (Fig. 3A) .
To identify postdisulfide determinants, the &-yjunction in G131D156G was stepped one residue at a time toward the C terminus (Fig. 3B) . The series of constructs produced highaffinity -like binding until serine-161 in ywas replaced by its 8 homologue, lysine-163, where intermediate affinity was observed, again similar in magnitude to that seen in the initial chimeras. The postdisulfide binding determinant therefore appears to be a single residue, serine-161 in y and lysine-163 in 6.
To look further for postdisulfide determinants, 8 sequence was added in an N-terminal direction to G175D225G (Fig.  3C) , which produced pure y-like binding in Fig. 2 . The first construct added the four 8 residues missing in all y subunits; among these four residues is a conserved arginine/lysine which might be expected to produce low affinity for a positively charged ligand such as DMT. The binding curve nevertheless showed high-affinity y-like binding. The second construct introduced the trio of consecutive glutamate residues found in 8, but still produced pure -y-like binding. These results strongly suggest that only one residue in the postdisulfide region affects DMT affmity, serine-161 in y and lysine-163 in 6.
The preceding results identify three residues in the 'y and 8 subunits likely to determine DMT selectivity. To confirm these assignments, point mutations were introduced into the three key positions of both subunits (Fig. 4) . For this discussion, mutants are designated according to the residues present at the three key positions I, II, and III, and mutant residues are underlined; pure 'y, for example, is G(IYS). In the y subunit, mutating a single residue to the corresponding 8 residue affected DMT affinity quantitatively, in line with affinity changes seen in the above described chimeras Introducing the three key y residues into the 8 subunit, singly or in combination, produced changes in DMT binding affinity roughly equal in magnitude but opposite in direction to those produced in the y subunit. Most important, pure highaffinity v-like binding was produced in the 8 subunit by simultaneous mutation of the three above identified residues (Fig. 4) . In the 8 subunit, however, quantitative changes in affinity were observed which provide insight into how the valine-isoleucine determinant affects DMT binding. These experiments identify residues in the y and 8 subunits that give the two binding sites in the AChR different affinity for curariform antagonists. Although it is tempting to conclude that these residues actually form part of the binding pocket, one cannot exclude an allosteric affect on the pocket. Electrostatic considerations, however, favor a direct shaping mechanism; the quaternary nitrogens in DMT would associate more tightly with tyrosine and serine in -y than with threonine and lysine in 6, in line with the measured subunit affinities. Also, the free energy of binding contributed by the pre-and postdisulfide determinants is roughly additive, as would be expected in a shaping mechanism but might not be expected in an allosteric one. Systematically varying residues at each position may shed further light on mechanism. These results also suggest that the y and 8 subunits contribute very similar basic scaffolds to the binding pocket and that the pre-and postdisulfide residues occupy equivalent positions within the 'y and 8 scaffolds. Considering a rigid ligand such as DMT, one would not expect the observed linear and interchangeable alterations in affinity if the preand postdisulfide determinants were not held in nearly the same positions at both the ao-y and ao-subunit interfaces.
While the pre-and postdisulfide residues determine selectivity of curare for the two binding sites, it is likely that other parts of the AChR further stabilize curare within each site. Photoaffinity labeling with d-tubocurarine reveals labeling of Proc. Natl. Acad. Sci. USA 90 (1993) homologous tryptophans in the y (W55) and 8 (W57) subunits (11); these residues do not affect selectivity, but may provide additional stabilizing interactions. Mutagenesis of residues in the a subunit also affects curare affinity (unpublished observations and ref. 12) , providing yet another possible source of stabilizing interactions. Combining results from mutagenesis studies with recent high-resolution images of the putative binding pocket suggests the following picture of the curarebinding domain. The ligand-binding pocket appears to be a gorge centered within the a subunit (13), but with one wall formed by the adjacent non-a subunit, presumably y or 8. The two quatemary nitrogens ofcurare are 10.8 A apart, a distance that would allow it to bridge from the center of the a portion of the binding pocket to the neighboring y or 8 subunit.
Structurally conspicuous is the disulfide loop bounded by the pre-and postdisulfide binding determinants. Containing 13 highly conserved residues between the two cysteines ( Fig.   2 ), this loop is found in all acetylcholine, y-aminobutyrate, glycine, and type 3 serotonin receptor subunits (10) . Also conspicuous is the high degree of sequence identity in the 10 residues preceding the loop and the four residues following it (Fig. 2) . Such strong conservation in this region supports the close structural similarity between the y and 8 subunits inferred from the present binding experiments. The functional significance of this loop must remain speculative, but its ubiquity among ligand-gated channel subunits and its proximity to the DMT binding determinants suggest roles either in contributing to the ligand-binding pocket or in coupling agonist binding to channel functions, such as opening or desensitization.
For the y subunit, the three binding determinants are well conserved among species for which these subunits have been sequenced [mouse (7, 8) , rat (14) , calf (15, 16) , chicken (17) , Xenopus (18) , Torpedo (19, 20) , and human (21, 22) ]. Determinant II is tyrosine in all species, determinant III is serine or threonine, and determinant I is isoleucine, valine, or methionine (Fig. 5) . Looking beyond the muscle AChR, one finds that certain y-aminobutyrate (23) and glycine (24) receptor subunits contain tyrosine in a position homologous to determinant II in y. This predisulfide tyrosine may therefore represent a binding-site signature in these non-AChR subunits.
Among 8 subunits, the three binding determinants are not well conserved across species (Fig. 5) . Determinant III is partially conserved, being arginine or lysine in all species except Torpedo, which has methionine. The most notable deviation is determinant II, a threonine in mouse, but tyrosine in calf, chicken, frog, and human. In species containing tyrosine at position II, y and 8 would differ only at positions I and III, thus predicting a much smaller difference in DMT affinity for the two sites. Of these species, only the human AChR has been examined for DMT binding; it shows only a 3-fold difference in the binding affinities of the two sites (25) , in contrast to the nearly 100-fold difference seen in mouse (9) . The general variation among 8 subunits suggests that the three binding determinants give rise to specificity among pharmacological ligands. Thus, homologous regions in other ligand-gated subunits represent logical places in which to look for determinants of ligand specificity.
Because DMT competes with agonist for the binding site, the three binding determinants are natural candidates for determinants of agonist specificity. However, the general lack of conservation in the 8 subunit makes it likely that the primary determinants for agonist are elsewhere. By analogy to the "aromatic gorge" that forms the acetylcholine binding site in acetylcholinesterase (26) , possible candidates are one or more of the seven conserved aromatic residues in and around the disulfide loop.
